Sign inJoin waitlistJoin the waitlist

Gerardo Colon-Otero

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Medical Oncology and Hematology University of Virginia Medical Center
1985–1987
Internal Medicine
Mayo Clinic College of Medicine and Science
1982–1985
Mayo Clinic College of Medicine and Science
1979–1982
University of Puerto Rico School of Medicine
1975–1979

Research

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG…
Journal of Clinical Oncology · 2014 · 753 citations
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Journal of Clinical Oncology · 2016 · 673 citations
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
JAMA Oncology · 2019 · 468 citations

EP
Edith Perez
16 papers
AM
Alvaro Moreno-Aspitia
9 papers
DM
David Menke
8 papers
Vivek Roy
7 papers
Asher Chanan-Khan
6 papers
James Foran
6 papers
Pooja Advani
6 papers
Ayalew Tefferi
5 papers
LS
Lawrence Solberg
5 papers
Sikander Ailawadhi
5 papers
AS
Abhisek Swaika
4 papers · 4 as a fellow
JC
John Camoriano
4 papers

Grants

Mayo Clinic Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $429.6K · Mayo Clinic Rochester
1997–2019

Clinical trials

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Principal investigator · Recruiting · Early phase 1
Mayo Clinic
2021–2029
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Principal investigator · Completed · Phase 4
Mayo Clinic
2020–2025
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
Principal investigator · Completed · Phase 2
Mayo Clinic
2016–2020
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Principal investigator · Completed · Phase 2
Mayo Clinic
2014–2018